Talk:Alirocumab

From WikiProjectMed
Jump to navigation Jump to search

FDA approval, but confusing wording by FDA apparently misinterpreted by CNN

I see that Praluent gained FDA approval. However, unless I'm more confused than I realize, it seems that a poor choice of wording in the FDA's announcement caused CNN to misinterpret what they meant:

FDA: "Praluent is an antibody that targets a specific protein, called PCSK9, which works by reducing the number of receptors on the liver that remove LDL cholesterol from the blood. By blocking PCSK9’s ability to work, more receptors are available to get rid of LDL cholesterol from the blood and, as a result, lower LDL cholesterol levels."

CNN: ' "The drug works by reducing the number of receptors on the liver that remove LDL cholesterol from the blood. By blocking PCSK9's ability to work, more receptors are available to get rid of LDL cholesterol from the blood and, as a result, lower LDL cholesterol levels," said the FDA.'

Seems to me that trying to make one long sentence leads to confusion regarding whether "which" refers to PCSK9 or to Praluent. I think the problem is compounded by using the words "works by", which we'd automatically want to associate with the drug. Gmporr (talk) 22:06, 24 July 2015 (UTC)[reply]

Yes, CNN is wrong. The receptors remove LDL and PCSK9 then degrades the receptors. The inhibitor inhibits PCSK9 from inhibiting the receptors from bringing in more blood LDL. Timetraveler3.14 (talk) 20:48, 25 July 2015 (UTC)[reply]

Criticism about cost removed without reason

This was removed but no reason was provided. Please be careful not to create a biased article by removing anything that could be considered critical, we do need to present more than just one side. Thanks, petrarchan47คุ 20:06, 25 July 2015 (UTC)[reply]

However, its cost can be prohibitive, at around $15,000 US per year, even for patients with insurance and prescription assistance.USA Today
there is a big "under construction" tag on the article. chill. Jytdog (talk) 20:13, 25 July 2015 (UTC)[reply]
Hm, I didn't read that in the same way you do. I'm not sure why you removed the USA Today article, or why you're arguing that for two hours no one can re-add it (except you?). Can you give me an idea from the guidelines how this is supported? petrarchan47คุ 20:24, 25 July 2015 (UTC)[reply]
The reason why the cost belongs in the article is that multiple WP:RSs refer to the cost. This establishes WP:WEIGHT.
The discussion in WP:MEDMOS about costs seems to be addressed at comparative price-shopping. It was written before super-expensive drug prices of $50,000, $100,000 and more a year became important. Now it is important (as judged by multiple references in WP:RS and WP:MEDRS). --Nbauman (talk) 20:33, 30 August 2015 (UTC)[reply]

price needs to be updated

prices have been reduced substantially, now costs about $6,000. Article needs to be updated. Pollira (talk) 21:25, 24 October 2018 (UTC)[reply]

NICE

Would it be worthwhile including this reference from NICE?[1] Bibeyjj (talk) 14:40, 8 February 2021 (UTC)[reply]

References

  1. ^ "Alirocumab". NICE. NICE. Retrieved 8 February 2021.

References

Wiki Education assignment: Plant Behavior 2022

This article was the subject of a Wiki Education Foundation-supported course assignment, between 28 March 2022 and 17 June 2022. Further details are available on the course page. Student editor(s): Taylorblackburn (article contribs). Peer reviewers: Rickstru.

— Assignment last updated by Gonet99 (talk) 19:16, 13 June 2022 (UTC)[reply]